Sai-Maurel C - Search Results

1

Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.

Faivre-Chauvet A, Gestin JF, Mease RC, Sai-Maurel C, Thédrez P, Slinkin M, Meinken GE, Srivastava SC, Chatal JF. Faivre-Chauvet A, et al. Nucl Med Biol. 1993 Aug;20(6):763-71. doi: 10.1016/0969-8051(93)90163-o. Nucl Med Biol. 1993. PMID: 8401377

2

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.

Mirallié E, Saï-Maurel C, Faivre-Chauvet A, Regenet N, Chang CH, Goldenberg DM, Chatal JF, Barbet J, Thedrez P. Mirallié E, et al. Among authors: sai maurel c. Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):901-9. doi: 10.1007/s00259-005-1811-2. Epub 2005 Apr 30. Eur J Nucl Med Mol Imaging. 2005. PMID: 15864584

3

Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma.

Slinkin MA, Curtet C, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF. Slinkin MA, et al. Bioconjug Chem. 1992 Nov-Dec;3(6):477-83. doi: 10.1021/bc00018a003. Bioconjug Chem. 1992. PMID: 1463777

4

Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.

Gestin JF, Faivre-Chauvet A, Mease RC, Sai-Maurel C, Thédrez P, Slinkin M, Meinken GE, Srivastava SC, Chatal JF. Gestin JF, et al. Nucl Med Biol. 1993 Aug;20(6):755-62. doi: 10.1016/0969-8051(93)90162-n. Nucl Med Biol. 1993. PMID: 8401376

5

Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.

Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF. Slinkin MA, et al. Nucl Med Biol. 1993 May;20(4):443-52. doi: 10.1016/0969-8051(93)90075-6. Nucl Med Biol. 1993. PMID: 8504286

6

Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.

Devys A, Thedrez P, Gautherot E, Faivre-Chauvet A, Saï-Maurel C, Rouvier E, Auget JL, Barbet J, Chatal JF. Devys A, et al. Int J Cancer. 1996 Sep 17;67(6):883-91. doi: 10.1002/(SICI)1097-0215(19960917)67:6<883::AID-IJC20>3.0.CO;2-1. Int J Cancer. 1996. PMID: 8824563

7

Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.

Faivre-Chauvet A, Mease RC, Chetanneau A, Bardiès M, Sai-Maurel C, Meinken GE, Srivastava SC, Chatal JF, Gestin JF. Faivre-Chauvet A, et al. Nucl Med Commun. 1996 Sep;17(9):781-9. doi: 10.1097/00006231-199609000-00008. Nucl Med Commun. 1996. PMID: 8895905

8

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.

Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A. Gestin JF, et al. J Nucl Med. 2001 Jan;42(1):146-53. J Nucl Med. 2001. PMID: 11197965 Free article.

9

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Faibre-Chauvet A, Saï-Maurel C, Gautherot E, Fiche M, Campion L, Le Boterff J, Barbet J, Chatal JF, Thédrez P. Kraeber-Bodéré F, et al. J Nucl Med. 1999 Jan;40(1):198-204. J Nucl Med. 1999. PMID: 9935077 Free article.

10

Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Saï-Maurel C, Campion L, Faivre-Chauvet A, Mirallié E, Chérel M, Supiot S, Barbet J, Chatal JF, Thédrez P. Kraeber-Bodéré F, et al. Among authors: sai maurel c. Mol Cancer Ther. 2002 Feb;1(4):267-74. Mol Cancer Ther. 2002. PMID: 12467222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters